Floatz logo

Therapeutic Asset Ratings

407 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
FLUOROURACILUM
Adenocarcinoma of the Colon
Merck Sharp & Dohme LLCP3BBB (77)
FLUOROURACILUM
Adenocarcinoma of the Rectum
Merck Sharp & Dohme LLCP3BBB (75)
Eloxatin
Adenocarcinoma of the Colon
Merck Sharp & Dohme LLCP3BBB (74)
Docetaxel
Prostatic Neoplasms
Merck Sharp & Dohme LLCP4BBB (73)
PREDNISONE TABLETS
Prostatic Neoplasms
Merck Sharp & Dohme LLCP3BBB (72)
Nicotine
Schizophrenia
Merck Sharp & Dohme LLCP4BB (71)
Carboplatin
Urinary Bladder Neoplasms
Merck Sharp & Dohme LLCP2BB (71)
Cyclophosphamide
Breast Neoplasms
Merck Sharp & Dohme LLCP4BB (70)
Cyclophosphamide
Follicular Lymphoma
Merck Sharp & Dohme LLCP4BB (70)
Inno-206
Breast Neoplasms
Merck Sharp & Dohme LLCP4BB (70)
PREDNISONE TABLETS
Follicular Lymphoma
Merck Sharp & Dohme LLCP4BB (70)
(+)-VINCRISTINE
Follicular Lymphoma
Merck Sharp & Dohme LLCP4BB (70)
Capecitabine
Gallbladder Cancer
Merck Sharp & Dohme LLCP3BB (70)
Cetuximab
Stage IV Colon Cancer
Merck Sharp & Dohme LLCP3BB (70)
Inno-206
Grade 3b Follicular Lymphoma
Merck Sharp & Dohme LLCP2/3BB (70)
Bendamustine
Follicular Lymphoma
Merck Sharp & Dohme LLCP4BB (69)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Follicular Lymphoma
Merck Sharp & Dohme LLCP4BB (69)
Everolimus
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP4BB (69)
Rocuronium
Neuromuscular Blockade
Merck Sharp & Dohme LLCP4BB (69)
Inno-206
Follicular Lymphoma
Merck Sharp & Dohme LLCP4BB (68)
DEXAMETHASONE
Primary Peritoneal Cavity Cancer
Merck Sharp & Dohme LLCP3BB (68)
Docetaxel
Neoplasm Metastasis
Merck Sharp & Dohme LLCP3BB (68)
LENVATINIB
Endometrial Neoplasms
Merck Sharp & Dohme LLCP3BB (68)
Levoleucovorin
Advanced/Metastatic Gastroesophageal Adenocarcinoma
Merck Sharp & Dohme LLCP3BB (68)
Levoleucovorin
Gastroesophageal Junction
Merck Sharp & Dohme LLCP3BB (68)
Showing 1 to 25 of 407 assets
PreviousPage 1 of 17Next